CPT code 82150 represents a quantitative laboratory assay for amylase, most often performed on serum or urine to assess pancreatic and salivary gland function. This test is commonly ordered in acute abdominal presentations, suspected pancreatitis, and some salivary gland disorders. As a widely used clinical chemistry test, its proper coding and billing affect inpatient and outpatient laboratory workflows and national utilization patterns.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides a national perspective on coding and utilization benchmarks, typical sites of service, clinical context for ordering the test, and payer considerations relevant to coverage and claims processing.

Readers will learn what CPT code 82150 denotes, the clinical situations in which the amylase assay is used, where the test is typically performed, and which major payers are included in the overview. The report also outlines expected elements for laboratory reporting and billing, and identifies where input data were not available. Data not available in the input: associated taxonomies, ICD-10 diagnoses, related codes, and service line specifics.